Additionally, SEMA5A could play a role in chemotherapy-induced peripheral neuropathy (CIPN) given that it is important in the guidance of axons in the central and peripheral nervous system and also that semaphorins are involved in diabetic neuropathy [59,66,67]. This evidence concerns the gene SEMA5A and diabetic neuropathy.